Back to search

Aristotle University Of Thessaloniki (AUTH)

Διερεύνηση των αντινεοπλασματικών ιδιοτήτων τετραθειούχου άλατος μολυβδαινικού οξέος στο ακανθοκυτταρικό καρκίνωμα του στόματος

Abstract

dc:description

Tetrathiomolybdate (TM) forms a ternary complex with copper and albumin and contributes to the reduction of copper levels in the organism and, has strong antitumor activity reducing the angiogenic potential of the tumor with minimal toxic effects. The purpose of this study is to examine the antitumor-antiangiogenic properties of TM in squamous cell carcinoma of the oral mucosa in a chemical carcinogenesis model using 4-NQO, by investigating the expression levels of VEGF, NO (NOS), microvascular density (MVD), and the inflammatory response (CD 68) in the tumor environment, and comparing it to the gradual reduction of Cu level in both precancerous and cancerous stages levels for preventative purposes. Materials and Methods. 70 Wistar male rats were used 4 months old weighing 200gr separated into 4 groups with different administration periods for TM. The control group A was divided into two subgroups. In subgroup A₁ only 4-NQO was administered for a total period of 30 weeks. In the subgroup A₂, 4-NQO was administered for a total period of 30 weeks, after the appearance of malignancy, TM was time for 17 weeks. In group B 4-NQO and TM were simultaneously administered for a total period of 40 weeks. Group C, was divided into 2 subgroups, the subgroup C₁ taking 4-NQO for 2 weeks and then TM. In the subgroup C₂ 4-NQO was first administered for 4 weeks and then TM. Group D also was divided into two subgroups, D₁ where TM was initially administered for 4 weeks, while the Cu plasma levels dropped to 20% of the total mean level, 4-NQO was administered. The simultaneous administration of both substances lasted 45 weeks. In the subgroup D₂ TM was initially administered for 2 weeks, while the Cu plasma levels dropped to 20% of the total mean level, then 4-NQO was administered. The simultaneous administration of both substances lasted 45 weeks. Results. The administration TM, at therapeutic level, seems to normalize tumor vasculature and fully reverses the angiogenic phenotype in squamous cell carcinoma of the oral cavity in the groups D₁ and D₂ that had prophylactic administration of TM. Conclusions. The administration of TM, proactively, appears to delay the onset of development of malignancy (45th week against the 23th week), and could be administered as chemoprophylaxis for developing second primary tumor in patients with squamous cell carcinoma of the oral cavity, as in healthy subjects risk.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2013

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Antoniades, Vassilios
  • Αντωνιάδης, Βασίλειος

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/35441

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Antoniades, Vassilios; Αντωνιάδης, Βασίλειος. Διερεύνηση των αντινεοπλασματικών ιδιοτήτων τετραθειούχου άλατος μολυβδαινικού οξέος στο ακανθοκυτταρικό καρκίνωμα του στόματος. Aristotle University Of Thessaloniki (AUTH), 2013. http://hdl.handle.net/10442/hedi/35441